Cross-scale models demonstrate vascular homeostatic failure in Long COVID, suggesting new therapeutic pathways.
AbstractLong COVID — the persistent syndrome affecting an estimated 10–30% of those infected withSARS-CoV-2 and more than 400 million people globally — has resisted explanation by conventionalsingle-cause models. Building on Smith (2025) [1], which proposed Long COVID as a form ofvascular homeostatic failure driven by microclot and neutrophil extracellular trap (NET)accumulation, this paper extends the framework in four directions. First, we apply a cross-scaleEcological Homeostasis Master Map, situating Long COVID within a comparative analysis of fourecological systems exhibiting analogous accumulation-driven failure cascades. Second, we presenta seven-scale Multi-Scale Failure Cascade model spanning molecular to population levels, withtestable biomarkers at each scale. Third, we propose and critically evaluate six novel hypotheses(H1–H6) derived from the v1 framework and refined through a three-stage adversarial SymbioMindpipeline (Mercury 2, Claude, DeepSeek), with all claims graded according to the establishedevidence gradient (Established / Preliminary / Hypothetical / Speculative). Fourth, we present aRevised Unified Failure Model integrating all six hypotheses into a flexible, two-phase systemsnetwork.Three critical errors identified in the generative pipeline were resolved prior to inclusion in this paper:a pharmacological misidentification (Roxadustat incorrectly proposed as HIF-1α inhibitor), anunsourced quantitative threshold (0.5% circulating fibrin), and a theoretical misframing of DNASE1deficiency as genetic rather than potentially acquired. A sixth hypothesis — the Metabolic Trap (H6),proposing mitochondrial dysfunction and metabolic reprogramming as a self-sustaining mechanismfor fatigue — is introduced as a novel contribution of the adversarial pipeline stage. The ecologicalanalogy is retained as a conceptual and communication framework while its limitations are explicitlyacknowledged: it is primarily a presentational device, not a hypothesis-generating mechanism, andthe goal of any therapeutic intervention must be to establish a new healthy equilibrium, not to restorea pre-existing vascular state.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: